Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion ; volume:20 ; number:1 ; day:31 ; month:10 ; year:2021 ; pages:1-12 ; date:12.2021
Lipids in health and disease ; 20, Heft 1 (31.10.2021), 1-12, 12.2021
- Urheber
-
Tallima, Hatem
Azzazy, Hassan M. E.
El Ridi, Rashika
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-021-01581-y
- URN
-
urn:nbn:de:101:1-2022010917452787570288
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tallima, Hatem
- Azzazy, Hassan M. E.
- El Ridi, Rashika
- SpringerLink (Online service)
Ähnliche Objekte (12)
LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis
Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
Zur enzymatischen Analytik des HDL-Sphingomyelin
Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin
Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy
Collagen density promotes mammary tumor initiation and progression
Instantaneous mutation rate in cancer initiation and progression
Evasión.
Sphingomyelin Synthases in Neuropsychiatric Health and Disease
Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation
Role of PRKDC in cancer initiation, progression, and treatment
Zur Initiation, Progression und Chronifizierung des allergischen Asthma bronchiale
LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis
Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
Zur enzymatischen Analytik des HDL-Sphingomyelin
Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin
Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy
Collagen density promotes mammary tumor initiation and progression
Instantaneous mutation rate in cancer initiation and progression
Evasión.
Sphingomyelin Synthases in Neuropsychiatric Health and Disease
Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation
Role of PRKDC in cancer initiation, progression, and treatment
Zur Initiation, Progression und Chronifizierung des allergischen Asthma bronchiale
LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis
Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
Zur enzymatischen Analytik des HDL-Sphingomyelin
Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin
Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy
Collagen density promotes mammary tumor initiation and progression
Instantaneous mutation rate in cancer initiation and progression
Evasión.
Sphingomyelin Synthases in Neuropsychiatric Health and Disease
Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation
Role of PRKDC in cancer initiation, progression, and treatment